Most Recent
Pharmaceutical giant Wyeth has accused Merck Sharp & Dohme of a "baseless" patent invalidity case, saying on the second day of trial over the world's best selling vaccine that the development of its patented Prevnar 13 pneumococcal shot was anything but obvious, as its rival contends.
Accounting giant Ernst & Young, which is accused in a class action of misleading and deceptive conduct in signing off on the 2015 and 2016 financial reports of sandalwood producer Quintis, has named the company's previous auditor as partly to blame in any finding of liability.
A showdown between global pharmaceutical giants over the world's best selling vaccine began Monday in Federal Court, with Merck Sharp & Dohme claiming three patents for Prevnar 13 sold by Pfizer's Wyeth are invalid and that its own vaccine offers greater protection against pneumococcal bacteria.
Grain supplier Seednet has agreed to pay $1 million to settle an enforcement action by the consumer watchdog alleging it misled farmers about the performance of its latest barley variety.
Real estate advertiser REA Group has won an emergency injunction against Domain that blocks its rival from authorising the owner of the US website realestate.com to redirect Australian traffic to Domain.
Online real estate giant REA Group is suing competitor Domain Group over a referral arrangement with the US-based owner of the web address realestate.com, saying the deal amounts to trade mark infringement and misleading and deceptive conduct.
Generic drug maker Sandoz has been found liable for patent infringement and misleading and deceptive conduct in a case by pharmaceutical giant Lundbeck over its blockbuster antidepressant Lexapro, ending a battle that has raged for 15 years.
Hotel booking aggregator Trivago has admitted it may have misled consumers into believing they would find the lowest hotel rate on an initial search of its site and that it had breached the Australian Consumer Law.
A late proposal by the Australian Law Reform Commission to introduce a 'leave to proceed' mechanism into class actions has been blasted by a major litigation funder and a plaintiffs-side law firm as a de facto class certification procedure that would ramp up costs and add years of delay to cases.
Squire Patton Boggs has refused a request by rival Phi Finney McDonald for the details of group members it signed up to its now stayed shareholder class action against GetSwift, a court has learned, in the latest show of resistance by the losing law firm.